Kopacz D J, Sharrock N E, Allen H W
Department of Anesthesiology, Virginia Mason Medical Center, Seattle, Washington 98111, USA.
Anesth Analg. 1999 Dec;89(6):1497-503. doi: 10.1097/00000539-199912000-00034.
Levobupivacaine, the isolated S(-) isomer of bupivacaine, is less cardiotoxic than racemic bupivacaine in animal studies. We studied the effectiveness of patient-controlled epidural analgesia (PCEA) with either levobupivacaine 0.125% or fentanyl 4 microg/mL alone, or a combination of levobupivacaine and fentanyl in 65 patients after total joint arthroplasty in a prospective, random, double-blinded fashion. Intraoperatively, all patients received 20 mL of 0.75% levobupivacaine. Study medication was infused at an initial rate of 4 mL/h, with additional medication available on patient demand (2 mL/10 min). The combination of levobupivacaine and fentanyl produced better analgesia (longer time to first PCEA request; P = 0.007 combination versus fentanyl and P = 0.006 combination versus levobupivacaine) than either drug alone. Patients in the levobupivacaine groups had appreciable sensory blockade to pinprick with minimal motor impairment. Resting and dynamic visual analog scale pain scores were lower in the combination group than in the plain fentanyl group at 6 (P = 0.022 and 0.036) and 12 h (P = 0.002 and 0.001). The 24-h overall patient- and investigator-rated visual analog scale pain scores were also lower in the combination group (resting P = 0.007, dynamic P = 0.005). There was no significant difference among the groups in the incidence of postoperative nausea (26.2%), pruritus (9.2%), hypotension (23.1%), or sedation (0%). We conclude that the analgesic effects of levobupivacaine 0.125% and fentanyl (4 microg/mL) are additive and beneficial for the management of orthopedic surgical pain by the PCEA method. Patients in this study began demand-dosing later, reported lower pain scores, and had no greater risk of adverse events than those who were given either levobupivacaine or fentanyl alone.
We demonstrated a significant additive effect of the combination of levobupivacaine (0.125%) and fentanyl (4 microg/mL), compared with either drug alone, when using patient-controlled epidural analgesia in patients after total joint arthroplasty.
左旋布比卡因是布比卡因的左旋(S-)异构体,在动物研究中,其心脏毒性低于消旋布比卡因。我们以前瞻性、随机、双盲的方式,对65例全关节置换术后患者进行了研究,比较单独使用0.125%左旋布比卡因或4μg/mL芬太尼,以及左旋布比卡因与芬太尼联合使用的患者自控硬膜外镇痛(PCEA)效果。术中,所有患者均接受20mL 0.75%左旋布比卡因。研究药物初始输注速度为4mL/h,患者有需求时可额外给药(2mL/10分钟)。与单独使用任何一种药物相比,左旋布比卡因与芬太尼联合使用产生了更好的镇痛效果(首次PCEA需求时间更长;联合用药组与芬太尼组相比P = 0.007,联合用药组与左旋布比卡因组相比P = 0.006)。左旋布比卡因组患者对针刺有明显的感觉阻滞,运动功能损害最小。联合用药组静息和动态视觉模拟评分疼痛分数在6小时(P = 0.022和0.036)和12小时(P = 0.002和0.001)时低于单纯芬太尼组。联合用药组24小时患者和研究者评定的视觉模拟评分疼痛分数也较低(静息P = 0.007,动态P = 0.005)。各组术后恶心(26.2%)、瘙痒(9.2%)、低血压(23.1%)或镇静(0%)的发生率无显著差异。我们得出结论,0.125%左旋布比卡因和芬太尼(4μg/mL)的镇痛效果具有相加性,通过PCEA方法对骨科手术疼痛的管理有益。本研究中的患者开始按需给药较晚,报告的疼痛分数较低,与单独给予左旋布比卡因或芬太尼的患者相比,不良事件风险没有更高。
我们证明,在全关节置换术后患者中使用患者自控硬膜外镇痛时,与单独使用任何一种药物相比,左旋布比卡因(0.125%)和芬太尼(4μg/mL)联合使用具有显著的相加效应。